Skip to content
10-K

Annual Report

Natus Medical Inc

0000878526-22-000026

← back to feed
Filed
Feb 25, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Feb 18, 2022 34.41M sh
Shares Diluted FY 2021 · Dec 31, 2021 33.97M sh
Shares Diluted FY 2021 · Dec 31, 2020 33.56M sh
Shares Diluted FY 2021 · Dec 31, 2019 33.7M sh
Stock Repurchased FY 2021 · Dec 31, 2021 $0
Stock Repurchased FY 2021 · Dec 31, 2020 $10.5M
Stock Repurchased FY 2021 · Dec 31, 2019 $0
Capex FY 2021 · Dec 31, 2021 $3.62M
Capex FY 2021 · Dec 31, 2020 $8.61M
Capex FY 2021 · Dec 31, 2019 $5.33M
Operating Cash Flow FY 2021 · Dec 31, 2021 $64M
Operating Cash Flow FY 2021 · Dec 31, 2020 $34.43M
Operating Cash Flow FY 2021 · Dec 31, 2019 $60.06M
Long Term Debt FY 2021 · Dec 31, 2021 $0
Long Term Debt FY 2021 · Dec 31, 2020 $5.84M
Cash And Equivalents FY 2021 · Dec 31, 2021 $75.6M
Cash And Equivalents FY 2021 · Dec 31, 2020 $82.08M
Cash And Equivalents FY 2021 · Dec 31, 2019 $63.3M
Cash And Equivalents FY 2021 · Dec 31, 2018 $56.37M
Stockholders Equity FY 2021 · Dec 31, 2021 $424.75M
Stockholders Equity FY 2021 · Dec 31, 2020 $411.09M
Stockholders Equity FY 2021 · Dec 31, 2019 $416.12M
Stockholders Equity FY 2021 · Dec 31, 2018 $398.44M
Current Liabilities FY 2021 · Dec 31, 2021 $114.6M
Current Liabilities FY 2021 · Dec 31, 2020 $145.75M
Total Liabilities FY 2021 · Dec 31, 2021 $139.54M
Total Liabilities FY 2021 · Dec 31, 2020 $189.3M
Current Assets FY 2021 · Dec 31, 2021 $277.29M
Current Assets FY 2021 · Dec 31, 2020 $271.7M
Total Assets FY 2021 · Dec 31, 2021 $564.29M
Total Assets FY 2021 · Dec 31, 2020 $600.39M
Eps Diluted FY 2021 · Dec 31, 2021 $0.39
Eps Diluted FY 2021 · Dec 31, 2020 −$0.49
Eps Diluted FY 2021 · Dec 31, 2019 −$0.47
Eps Basic FY 2021 · Dec 31, 2021 $0.39
Eps Basic FY 2021 · Dec 31, 2020 −$0.49
Eps Basic FY 2021 · Dec 31, 2019 −$0.47
Sga Expense FY 2021 · Dec 31, 2021 $52.75M
Sga Expense FY 2021 · Dec 31, 2020 $49.11M
Sga Expense FY 2021 · Dec 31, 2019 $59.65M
Rd Expense FY 2021 · Dec 31, 2021 $56.31M
Rd Expense FY 2021 · Dec 31, 2020 $61.3M
Rd Expense FY 2021 · Dec 31, 2019 $58.73M
Net Income FY 2021 · Dec 31, 2021 $13.18M
Net Income FY 2021 · Dec 31, 2020 −$16.61M
Net Income FY 2021 · Dec 31, 2019 −$15.67M
Operating Income FY 2021 · Dec 31, 2021 $23.78M
Operating Income FY 2021 · Dec 31, 2020 −$20.19M
Operating Income FY 2021 · Dec 31, 2019 −$15.67M
Gross Profit FY 2021 · Dec 31, 2021 $273.68M
Gross Profit FY 2021 · Dec 31, 2020 $216.53M
Gross Profit FY 2021 · Dec 31, 2019 $291.71M
Revenue FY 2021 · Dec 31, 2021 $473.44M
Revenue FY 2021 · Dec 31, 2020 $415.68M
Revenue FY 2021 · Dec 31, 2019 $495.18M